CD22 is not expressed merely on B cells: Comment on the article by Vos et al

Arthritis and Rheumatism

Volumn 58, Issue 3, 2008, Pages 911-912

  Teng, Y K O ^a   Engels, M C ^a   Van Laar, Y M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD22 ANTIGEN; RITUXIMAB;

ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; B LYMPHOCYTE; HUMAN; HUMAN CELL; LETTER; LYMPHOCYTE DEPLETION; LYMPHOCYTE SUBPOPULATION; MONONUCLEAR CELL; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIUM;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD19; ANTIGENS, CD20; ANTIGENS, CD22; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; B-LYMPHOCYTE SUBSETS; B-LYMPHOCYTES; HUMANS; SENSITIVITY AND SPECIFICITY; SYNOVIAL MEMBRANE;

EID: 40549126918     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.23282     Document Type: Letter

References (4)

1. Vos K, Thurlings RM, Wijbrandts CA, van Schaardenburg D, Gerlag DM, Tak PP. Early effects of rituximab on the synovial cell infiltrate in patients with rheumatoid arthritis. Arthritis Rheum 2007;56:772-8.
2. Teng YK, Levarht EW, Hashemi M, Bajema IM, Toes RE, Huizinga TW, et al. B cell activity in synovium predicts responsiveness to rituximab in patients with refractory rheumatoid arthritis. Arthritis Rheum 2007;56:3909-18.
3. Han K, Kim Y, Lee J, Lim J, Lee KY, Kang CS, et al. Human basophils express CD22 without expression of CD19. Cytometry 1999;37:178-83.
4. Yokoi H, Myers A, Matsumoto K, Crocker PR, Saito H, Bochner BS. Alteration and acquisition of Siglecs during in vitro maturation of CD34+ progenitors into human mast cells. Allergy 2006;61:769-76.